Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register

Janneke Anink*, Marieke H. Otten, Femke H. M. Prince, Esther P. A. H. Hoppenreijs, Nico M. Wulffraat, Joost F. Swart, Rebecca ten Cate, Marion A. J. van Rossum, J. Merlijn van den Berg, Koert M. Dolman, Yvonne Koopman-Keemink, Wineke Armbrust, Sylvia Kamphuis, Philomine A. van Pelt, Simone L. Gorter, Lisette W. A. van Suijlekom-Smit

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Web of Science)
Original languageEnglish
Pages (from-to)712-717
Issue number4
Publication statusPublished - Apr 2013


  • oligoarticular juvenile idiopathic arthritis
  • etanercept
  • adalimumab
  • response
  • anti-tumour necrosis factor
  • biologic therapy

Cite this